Biotech

Browse the latest news about Southern California's biotech startups and ecosystem from dot.LA.
Photo courtesy of Peachy

When Lex Oiler, co-founder and CEO of Los Angeles-based health care payments startup Peachy, first met for coffee with Roshan Patel, her counterpart at New York-based Walnut, she says she tried to break the ice by asking, “So—mergers and acquisitions?”

The quip came from the fact that many venture capital investors viewed the two startups as competitors, according to the founders, since both are tackling the complex web of health care payments. Walnut allows patients to pay large medical bills in manageable installments, while Peachy streamlines payment collection while also helping patients maintain and improve their credit scores.

Read more Show less
Courtesy of Eyedaptic

A longtime executive at successful companies, Jay Cormier had been thinking about retiring in 2010.

At the time, Teridian Semiconductor, where he served as vice president and general manager, was acquired for $315 million. Cormier was working on a side project helping some entrepreneur friends with an augmented reality idea.

Around the same time, macular degeneration forced his grandmother into an assisted living facility.

That got him wondering whether AR could help the visually-impaired.

Read more Show less
Image courtesy of ImmPACT Bio

When Sumant Ramachandra first stumbled upon oncology startup ImmPACT Bio, the Harvard Medical physician-turned-pharmaceutical executive was preparing to move his family to Los Angeles from Illinois, where he had worked as Baxter International’s president of pharmaceuticals. Though he had spent recent years running research and development arms and managing regulatory processes, Ramachandra’s background in immunology and oncology drew him to the company.

“It was a bit like coming home—and very humbling to see how far the field has gone from the time I was a researcher in the late 1990s to where it is today,” Ramachandra said.

Read more Show less
Trending